Development ofNovel Compounds to Treat Autoimmune and Inflammatory Diseases and Graft Versus Host Reactions

E-ISSN： 2212-3873|7|2|93-97

ISSN： 1871-5303

Source： Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.7, Iss.2, 2007-06, pp. : 93-97

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Monoclonal Antibodies to Treat Graft-Versus-Host Disease

Mini Reviews in Medicinal Chemistry, Vol. 11, Iss. 6, 2011-06 ,pp. : 473-479

Bentham Science Publishers

Access to resources Recommend Favorite

Novel therapeutics for the treatment of graft-versus-host disease

By Jacobsohn David A

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 9, 2002-09 ,pp. : 1271-1280

Informa Healthcare

Access to resources Recommend Favorite

Novel approaches to the treatment of chronic graft-versus-host disease

By Gaziev D. Lucarelli G.

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 5, 2001-05 ,pp. : 909-923

Informa Healthcare

Access to resources Recommend Favorite

Immunoproteasome-Selective Inhibitors: A Promising Strategy to Treat Hematologic Malignancies, Autoimmune and Inflammatory Diseases

Current Medicinal Chemistry, Vol. 23, Iss. 12, 2016-05 ,pp. : 1217-1238

Bentham Science Publishers

Access to resources Recommend Favorite

Chronic Graft-Versus-Host Disease

Current Pharmaceutical Design, Vol. 14, Iss. 20, 2008-07 ,pp. : 1974-1986

Bentham Science Publishers

Access to resources Recommend Favorite